🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for PSA

Optimal PSA Triggered Individual Management of Androgen Sensitive Prostate Cancer NCT07216248Phase 21 site📍 Salt Lake City University of Utah · Tests: relugolix + ARPI, Intermittent- Relugolix or androgen deprivation therapy (ADT) + ARPI, relugolix or androgen deprivati… Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy NCT07516886n/a1 site📍 Kaunas Lithuanian University of Health Sciences · Tests: Radical Prostatectomy PSMA-RLT in Biochemically Recurrent PCa NCT06220188Phase 21 site📍 Vienna Medical University of Vienna · Tests: [177Lu]Lu-PSMA I&T HIPPOCRATES Prospective Observational Study NCT05858528n/a1 site📍 Oxford University of Oxford · Tests: PEST screening questionnaire Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05) NCT07711002Phase 3210 sites📍 Hot Springs📍 Springdale📍 Beverly Hills AstraZeneca · Tests: Saruparib, Placebo, Enzalutamide, Darolutamide, Abiraterone APACHE Cohort (A Psoriatic Arthritis CoHort) NCT03768271n/a3 sites📍 Créteil📍 Montpellier📍 Paris Assistance Publique - Hôpitaux de Paris Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders) NCT06496581Phase 325 sites📍 Angers📍 Bordeaux📍 Brest UNICANCER · Tests: 177Lu-PMSA-617, Standard of Care Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer NCT06631521Phase 11 site📍 Orlando AdventHealth · Tests: Darolutamide, Relugolix, Radical Prostatectomy REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases NCT07160231Phase 47 sites📍 Nijmegen📍 Maastricht📍 Tilburg Sint Maartenskliniek · Tests: JAKi dose reduction strategy, JAKi disease activity guided continuation of same dose strategy Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578Phase 12 sites📍 Charlestown📍 Birtinya Seismic Therapeutic AU Pty Ltd · Tests: S-4321 Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis NCT07286058Phase 378 sites📍 Tucson📍 Fountain Valley📍 La Mesa Takeda · Tests: Zasocitinib Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response NCT06592924Phase 3395 sites📍 Anchorage📍 Anchorage📍 Anchorage Canadian Cancer Trials Group · Tests: Abiraterone, Enzalutamide, Apalutamide, Darolutamide (BAY 1841788), Docetaxel Sex and Gender-based Analysis of the Effectiveness of Advanced Therapies in Psoriatic Arthritis NCT05954364n/a1 site📍 Toronto Women's College Hospital Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI NCT04812431Phase 1, Phase 22 sites📍 Suwon📍 Seoul S.Biomedics Co., Ltd. · Tests: Neural precursor cells derived from human embryonic stem cell line Study of Oral MRT-2359 With Apalutamide in Prostate Cancer NCT07745361Phase 214 sites📍 Los Angeles📍 Newport Beach📍 Colorado Springs Monte Rosa Therapeutics, Inc · Tests: Oral MRT-2359, Apalutamide MRI-Assisted Guidance for Non-Essential Tissue Sampling NCT07516223NA1 site📍 Shanghai Shanghai East Hospital · Tests: Paired Prostate Biopsy Cohort (TB + SB) The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study). NCT06636526n/a3 sites📍 Sutton📍 London📍 Sutton Institute of Cancer Research, United Kingdom · Tests: The i4i PRODICT® test., Prostate cancer screening, MRI Scan, Prostate Biopsy Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen NCT05512754Phase 43 sites📍 Chicago📍 Albany📍 Hershey University of Chicago · Tests: Ibuprofen 400 mg Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer NCT04692675NA1 site📍 Bethesda National Cancer Institute (NCI) · Tests: mpMRI Phase III Randomized International Open Label Clinical Trial of Treatment Intensification With Docetaxel Plus Apalutamide in Patients With Metastatic Hormone-sensitive Prostate Cancer Who Did Not Achieve a Deep PSA Response After Initial Treatment With Apalutamide: REINFORCE Trial. NCT07333066Phase 356 sites📍 Bayonne📍 Bordeaux📍 Brest Alianza multidisciplinar para la investigación de los tumor… · Tests: Apalutamide (Erleada™) 60 mg or 240 mg tablets, Docetaxel Preventing Structural Damage in Early Psoriatic Arthritis NCT07486843Phase 41 site📍 Hong Kong Chinese University of Hong Kong · Tests: Amgevita 40Mg Solution for Injection, Methotrexate (Metoject® prefilled pen) EDRN Prostate MRI Biomarker Study NCT03784924n/a1 site📍 Ann Arbor University of Michigan · Tests: MRI prostate Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor NCT07166315n/a1 site📍 Bath Adelphi Real World · Tests: observational study Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III) NCT07762911NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: MRI AYLo - AutoimmunitY and Loss of y NCT06696027n/a1 site📍 Bonn University of Bonn · Tests: Single nucleotide polymorphisms (SNP), 3'mRNA sequencing, Enzyme-linked immunosorbent assay (ELISA) and Legendplex… MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer NCT05241236n/a1 site📍 Miami Lakes Urological Research Network, LLC · Tests: Image Fusion (MR/US) Software Registration Guided Laser Ablation of Prostate Cancer Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer NCT03833921Phase 23 sites📍 Houston📍 Houston📍 Houston Martha Mims · Tests: Abiraterone Acetate, Prednisone Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA NCT06600698Phase 1, Phase 21 site📍 Hershey Milton S. Hershey Medical Center · Tests: INM176 Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial NCT07111494Phase 41 site📍 Milwaukee Medical College of Wisconsin · Tests: GLP-1 agonists, Nutrition Counseling A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis NCT06869551Phase 348 sites📍 Lancaster📍 Chicago📍 Indianapolis Bristol-Myers Squibb · Tests: Deucravacitinib, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy